ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $475,000 | -40.2% | 11,738 | -14.8% | 0.01% | -33.3% |
| Q2 2015 | $794,000 | -15.9% | 13,778 | -7.0% | 0.02% | -16.7% |
| Q1 2015 | $944,000 | +39.2% | 14,813 | +34.0% | 0.02% | +20.0% |
| Q4 2014 | $678,000 | +99.4% | 11,052 | +26.3% | 0.02% | +66.7% |
| Q3 2014 | $340,000 | +51.8% | 8,751 | +34.1% | 0.01% | +50.0% |
| Q2 2014 | $224,000 | +8.7% | 6,527 | +38.3% | 0.01% | 0.0% |
| Q1 2014 | $206,000 | -19.5% | 4,721 | -26.6% | 0.01% | -25.0% |
| Q4 2013 | $256,000 | +19.1% | 6,433 | +12.3% | 0.01% | +14.3% |
| Q3 2013 | $215,000 | +38.7% | 5,727 | -0.3% | 0.01% | +16.7% |
| Q2 2013 | $155,000 | – | 5,746 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |